Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

HSV-2: in pursuit of a vaccine.

Johnston C, Koelle DM, Wald A.

J Clin Invest. 2011 Dec;121(12):4600-9. doi: 10.1172/JCI57148. Epub 2011 Dec 1. Review.

2.

Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.

Jones CA, Cunningham AL.

Herpes. 2004 Apr;11(1):12-7. Review.

PMID:
15115632
3.

HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection.

Roth K, Ferreira VH, Kaushic C.

Microb Pathog. 2013 May;58:45-54. doi: 10.1016/j.micpath.2012.11.001. Epub 2012 Nov 15. Review.

PMID:
23159485
4.

Epidemiology of herpes simplex virus types 2 and 1 amongst men who have sex with men attending sexual health clinics in England and Wales: implications for HIV prevention and management.

Hill C, McKinney E, Lowndes CM, Munro H, Murphy G, Parry JV, Gill ON; GUM Anon Network.

Euro Surveill. 2009 Nov 26;14(47). pii: 19418.

5.

Development of prophylactic vaccines for genital and neonatal herpes.

Jones CA, Cunningham AL.

Expert Rev Vaccines. 2003 Aug;2(4):541-9. Review.

PMID:
14711338
6.

Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.

Çuburu N, Wang K, Goodman KN, Pang YY, Thompson CD, Lowy DR, Cohen JI, Schiller JT.

J Virol. 2015 Jan;89(1):83-96. doi: 10.1128/JVI.02380-14. Epub 2014 Oct 15.

7.

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.

Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM Jr, Handsfield HH, Warren T, Marr L, Tyring S, DiCarlo R, Adimora AA, Leone P, Dekker CL, Burke RL, Leong WP, Straus SE.

JAMA. 1999 Jul 28;282(4):331-40.

PMID:
10432030
8.

Current status and prospects for development of an HSV vaccine.

Johnston C, Koelle DM, Wald A.

Vaccine. 2014 Mar 20;32(14):1553-60. doi: 10.1016/j.vaccine.2013.08.066. Epub 2013 Sep 6.

9.

Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.

Gorfinkel IS, Aoki F, McNeil S, Dionne M, Shafran SD, Zickler P, Halperin S, Langley J, Bellamy A, Schulte J, Heineman T, Belshe R.

Int J STD AIDS. 2013 May;24(5):345-9. doi: 10.1177/0956462412472822.

PMID:
23970700
10.

The challenge of developing a herpes simplex virus 2 vaccine.

Dropulic LK, Cohen JI.

Expert Rev Vaccines. 2012 Dec;11(12):1429-40. doi: 10.1586/erv.12.129. Review.

11.

Genital herpes and public health: addressing a global problem.

Corey L, Handsfield HH.

JAMA. 2000 Feb 9;283(6):791-4.

PMID:
10683059
12.

Neonatal herpes simplex virus infection.

Cherpes TL, Matthews DB, Maryak SA.

Clin Obstet Gynecol. 2012 Dec;55(4):938-44. doi: 10.1097/GRF.0b013e31827146a7.

13.
14.

Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.

Bernard MC, Barban V, Pradezynski F, de Montfort A, Ryall R, Caillet C, Londono-Hayes P.

PLoS One. 2015 Apr 2;10(4):e0121518. doi: 10.1371/journal.pone.0121518. eCollection 2015.

15.

The acquisition of herpes simplex virus during pregnancy.

Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L.

N Engl J Med. 1997 Aug 21;337(8):509-15.

17.

Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.

Drake AL, John-Stewart GC, Wald A, Mbori-Ngacha DA, Bosire R, Wamalwa DC, Lohman-Payne BL, Ashley-Morrow R, Corey L, Farquhar C.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):403-9. Erratum in: Obstet Gynecol. 2007 Apr;109(4):1002-3.

PMID:
17267842
18.

Herpes simplex virus type 2 vaccines: new ground for optimism?

Aurelian L.

Clin Diagn Lab Immunol. 2004 May;11(3):437-45. Review.

19.

Seroprevalence of HSV-1 and HSV-2 in Barbados.

Levett PN.

Med Microbiol Immunol. 2005 Jan;194(1-2):105-7.

PMID:
15156399
20.

Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.

Stanberry LR.

Herpes. 2004 Aug;11 Suppl 3:161A-169A. Review.

PMID:
15319086

Supplemental Content

Support Center